A novel oral colon-targeting drug delivery system based on resistant starch acetate

J Control Release. 2011 Nov 30:152 Suppl 1:e51-2. doi: 10.1016/j.jconrel.2011.08.116.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Chemistry, Pharmaceutical
  • Chromatography, High Pressure Liquid
  • Colon / metabolism*
  • Drug Carriers*
  • Drug Compounding
  • Gastric Juice / chemistry
  • Hepatocyte Growth Factor / administration & dosage
  • Hepatocyte Growth Factor / chemistry*
  • Hepatocyte Growth Factor / metabolism
  • Insulin / administration & dosage
  • Insulin / chemistry*
  • Insulin / metabolism
  • Intestinal Secretions / chemistry
  • Kinetics
  • Mesalamine / administration & dosage
  • Mesalamine / chemistry*
  • Mesalamine / metabolism
  • Microscopy, Electron, Scanning
  • Molecular Weight
  • Plasticizers / chemistry
  • Serum Albumin, Bovine / administration & dosage
  • Serum Albumin, Bovine / chemistry*
  • Serum Albumin, Bovine / metabolism
  • Solubility
  • Starch / analogs & derivatives*
  • Starch / chemistry
  • Tablets, Enteric-Coated
  • Technology, Pharmaceutical / methods

Substances

  • Drug Carriers
  • Insulin
  • Plasticizers
  • Tablets, Enteric-Coated
  • Serum Albumin, Bovine
  • Mesalamine
  • Hepatocyte Growth Factor
  • Starch
  • starch acetate